These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21136899)

  • 21. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: Early detection of chronic kidney disease in Australia: which way to go?
    Mathew T; Corso O
    Nephrology (Carlton); 2009 Jun; 14(4):367-73. PubMed ID: 19563377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES).
    Lee SW; Kim YC; Oh SW; Koo HS; Na KY; Chae DW; Kim S; Chin HJ
    Nephrol Dial Transplant; 2011 Dec; 26(12):3975-80. PubMed ID: 21454352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of chronic kidney disease in Iran: a screening program is of essential need.
    Nafar M; Mousavi SM; Mahdavi-Mazdeh M; Pour-Reza-Gholi F; Firoozan A; Einollahi B; Lessan-Pezeshki ML; Asbaghi-Namini S; Farrokhi F
    Iran J Kidney Dis; 2008 Oct; 2(4):183-92. PubMed ID: 19377235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic kidney disease: novelties and scope of follow-up by the primary care physician].
    Sánchez Hernández R
    Nefrologia; 2008; 28 Suppl 5():113-7. PubMed ID: 18847430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
    Targher G; Chonchol M; Zoppini G; Abaterusso C; Bonora E
    J Hepatol; 2011 May; 54(5):1020-9. PubMed ID: 21145850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model.
    Villanueva S; Ewertz E; Carrión F; Tapia A; Vergara C; Céspedes C; Sáez PJ; Luz P; Irarrázabal C; Carreño JE; Figueroa F; Vio CP
    Clin Sci (Lond); 2011 Dec; 121(11):489-99. PubMed ID: 21675962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.
    Blanco-Colio LM; Martín-Ventura JL; Carrero JJ; Yilmaz MI; Moreno JA; Gómez-Guerrero C; Ortiz A; Egido J
    Proteomics Clin Appl; 2011 Jun; 5(5-6):281-8. PubMed ID: 21538911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?
    Davison SN; Davison JS
    J Pain Symptom Manage; 2011 Apr; 41(4):768-78. PubMed ID: 21269798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive function in chronic kidney disease.
    Madero M; Gul A; Sarnak MJ
    Semin Dial; 2008; 21(1):29-37. PubMed ID: 18251955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Birth weight and stages of CKD: a case-control study in an Australian population.
    Al Salmi I; Hoy WE; Kondalsamy-Chennakes S; Wang Z; Healy H; Shaw JE
    Am J Kidney Dis; 2008 Dec; 52(6):1070-8. PubMed ID: 18640755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of chronic kidney disease in Thai adult population.
    Chittinandana A; Chailimpamontree W; Chaloeiphap P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S112-20. PubMed ID: 17044462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of chronic kidney disease in Italy: possible therapeutical approaches.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Nephrol; 2003; 16(1):1-10. PubMed ID: 12649529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease management programs for CKD patients: the potential and pitfalls.
    Rocco MV
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S56-63. PubMed ID: 19231762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.